2,7-disubstituted cephalosporin derivatives as beta-lactamase substrates and methods for their use for the diagnosis of tuberculosis
US-9834681-B2 · Dec 5, 2017 · US
US10370538B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10370538-B2 |
| Application number | US-201615001591-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 20, 2016 |
| Priority date | Aug 11, 2015 |
| Publication date | Aug 6, 2019 |
| Grant date | Aug 6, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The compositions of the present disclosure provide novel fluorogenic probes for use in the specific imaging and detection of mycobacteria species, and in particular β-lactam-antibiotic resistant. Specificity for mycobacteria is conferred on these probes by incorporating a moiety that specifically targets the unique trapping mechanism of the DprE1 found in in mycobacteria. Accordingly, only Mycobacteria species that express both a β-lactamase and DprE1 enable both the activation of the caged fluorescent probe, and the affixing of the released fluorescent probes to the bacteria cells through the functioning reduction-covalent binding mechanism. Advantageously, such a probe is able, at its most sensitive, to allow single mycobacterium detection.
Opening claim text (preview).
The invention claimed is: 1. A probe specific for a mycobacterium, said probe comprising a β-lactamase substrate group covalently attached to a detectable label group, wherein the β-lactamase substrate group has the formula VI: wherein, in the β-lactamase substrate group: n=0 or 1; R 4 is selected from the group consisting of: a hydrogen, an alkyl, a substituted alkyl, an alkoxy, an alkoxycarbonyl, an alkoxyl, an alkoxyalkyl, an alkylene, an aralkoxycarbonyl, an aralkyl, an aralkyloxyl, an aroyl, an aroylamino, an aryl, a substituted aryl group, a carbamoyl, a carbonyl, a carboxamide, a carboxyl, a heteroaryl, a heterocyclic, a hydroxyalkyl, a substituted alkenyl, a substituted cycloaliphatic, a substituted aliphatic, a thiol, a thioalkoxy, a thioalkyl, a thioaryl, a thiophene, or a substituted thiophene; R 5 is Me, —CH 2 CH 3 , —CF 3 , —CH 2 CF 3 , —CF 2 CH 3 , —CHF 2 , —CH 2 F, —OCH 2 F, or OCHF 2 ; R 6 and R 7 are each H or and R 8 is O or S, and wherein the detectable label has a caging group covalently attached thereto by an esterase-cleavable ester bond, wherein the detectable label is a fluorophore or a dye having the caging group covalently attached thereto by an esterase-cleavable ester bond, wherein said caging group is an acetoxymethyl group. 2. A probe specific for a mycobacterium, said probe comprising a β-lactamase substrate group covalently attached to a detectable label group, wherein the β-lactamase substrate group has the formula VI: wherein, in the β-lactamase substrate group: n=0 or 1; R 4 is selected from the group consisting of: a hydrogen, an alkyl, a substituted alkyl, an alkoxy, an alkoxycarbonyl, an alkoxyl, an alkoxyalkyl, an alkylene, an aralkoxycarbonyl, an aralkyl, an aralkyloxyl, an aroyl, an aroylamino, an aryl, a substituted aryl group, a carbamoyl, a carbonyl, a carboxamide, a carboxyl, a heteroaryl, a heterocyclic, a hydroxyalkyl, a substituted alkenyl, a substituted cycloaliphatic, a substituted aliphatic, a thiol, a thioalkoxy, a thioalkyl, a thioaryl, a thiophene, or a substituted thiophene; R 5 is Me, —CH 2 CH 3 , —CF 3 , —CH 2 CF 3 , —CF 2 CH 3 , —CHF 2 , —CH 2 F, —OCH 2 F, or —OCHF 2 ; R 6 and R 7 are each H or and R 8 is O or S, and wherein the detectable label has a caging group covalently attached thereto by an esterase-cleavable ester bond, said probe further comprising a mycobacterium -specific decaprenylphosphoryl-β-D-ribose 2′-epimerase (DprE1)-trapping moiety, or an ester or salt thereof, said DprE1-trapping moiety covalently attached to the detectable label. 3. The probe of claim 2 , wherein said mycobacterium -specific DprE1-trapping moiety is covalently attached to the detectable label by a first linker. 4. The probe of claim 2 , wherein said mycobacterium -specific DprE1-trapping moiety has the formula: and wherein R 1 is H, —NO 2 , or CF 3 . 5. The probe of claim 2 , wherein the first linker is selected from the group consisting of: ethoxyphenyl, —CH 2 —CH 2 —, -1-ethyl 3-methyl 1,2,3-triazole, and —CH 2 —CH 2 —NR 2 —CS—NH 2 —, wherein R 2 is H or —CH 3 . 6. A probe specific for a mycobacterium, wherein the probe is selected from the group consisting of: wherein R 9 is each independently Me, —CH 2 CH 3 , —CF 3 , —CH 2 CF 3 , —CF 2 CH 3 , —CHF 2 , —CH 2 F, —OCH 2 F, or —OCHF 2 .
Methylene radicals, substituted by sulfur atoms · CPC title
with the 7-amino radical acylated by an araliphatic carboxylic acid, which is substituted on the aliphatic radical by hetero atoms · CPC title
Phthaleins containing amino groups {; Phthalanes; Fluoranes; Phthalides; Rhodamine dyes; Phthaleins having heterocyclic aryl rings; Lactone or lactame forms of triarylmethane dyes} · CPC title
for bacteria · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.